Fortive 과거 순이익 실적
과거 기준 점검 4/6
Fortive의 수입은 연평균 -16.8%의 비율로 감소해 온 반면, Machinery 산업은 수입이 연평균 8.3% 증가했습니다. 매출은 연평균 2.5%의 비율로 감소해 왔습니다. Fortive의 자기자본이익률은 9.1%이고 순이익률은 13.1%입니다.
핵심 정보
-16.77%
순이익 성장률
-16.57%
주당순이익(EPS) 성장률
| Machinery 산업 성장률 | 8.77% |
| 매출 성장률 | -2.48% |
| 자기자본이익률 | 9.14% |
| 순이익률 | 13.14% |
| 최근 순이익 업데이트 | 03 Apr 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • Jun 04
FTV: Buybacks And Sequential Execution Will Support Future EPS Upside
Fortive's analyst price target is modestly higher, with recent Street research pointing to a series of $1 to $7 upward target revisions as analysts highlight sequential growth and adjust assumptions around revenue, margins, and future P/E multiples. Analyst Commentary Recent Street research on Fortive has leaned constructive, with several bullish analysts adjusting targets upward and one trimming a target by a small amount.내러티브 업데이트 • May 20
FTV: Buybacks And Sequential Execution Will Support Future Earnings Quality
Fortive's analyst price target has been raised by several firms in recent research, collectively edging higher by single digits in dollar terms. Analysts point to solid sequential growth and recent company execution to support slightly higher revenue growth and P/E expectations, even as profit margin assumptions are trimmed and the discount rate is nudged up.내러티브 업데이트 • May 02
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.
내러티브 업데이트 • Apr 16
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Seeking Alpha • Apr 14
Fortive: Starting To Improve Its Performance
Summary Fortive has executed well post-Ralliant spin-off, delivering solid earnings and modest organic growth, supporting a fair valuation. Fortive's 2025 sales rose 2% to $4.16B, with 4Q organic growth exceeding 3%; adjusted EPS reached $2.71, up $0.30 YoY. Guidance targets 2026 adjusted EPS of $2.90–$3.00, underpinned by 2–3% organic growth, margin gains, and continued buybacks. At 19–20x forward earnings and leverage in the mid-2s, Fortive offers reasonable value, though upside is capped without stronger growth catalysts. Read the full article on Seeking Alpha내러티브 업데이트 • Apr 02
FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.내러티브 업데이트 • Mar 19
FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.내러티브 업데이트 • Mar 05
FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.
내러티브 업데이트 • Feb 19
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.내러티브 업데이트 • Feb 04
FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.내러티브 업데이트 • Jan 21
FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.내러티브 업데이트 • Jan 06
FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.분석 기사 • Dec 27
Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Key Insights The projected fair value for Fortive is US$53.12 based on 2 Stage Free Cash Flow to Equity Current share...내러티브 업데이트 • Dec 15
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.내러티브 업데이트 • Oct 20
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.내러티브 업데이트 • Sep 18
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.내러티브 업데이트 • Sep 03
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.Seeking Alpha • Mar 10
Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Summary Fortive's fourth-quarter results (and full 2024 results) showed fairly ordinary performance, with revenue and margins missing targets, and the business model didn't meaningfully outperform peers through the cycle. 2025 should be a better year, and I'd expect Fortive's businesses to recover ahead of more manufacturing and machinery-focused peers. The upcoming split of Precision Technologies into Ralliant may reduce complexity but is unlikely to significantly add or destroy value, but I can see potential strategic bidders for Tektronix. Despite cautious optimism for 2025, FTV's valuation doesn't justify a premium, given its inability to outgrow inflation and deliver superior full-cycle performance. Read the full article on Seeking AlphaSeeking Alpha • Dec 11
Fortive Corporation: Undervaluation And Stability Give It An Edge (Rating Upgrade)
Summary Fortive Corporation's product innovations and increased bookings, particularly in cloud-based solutions, support a recovery by 2025 despite macro uncertainties delaying short-term growth. The company’s strong cash flow, robust liquidity, and undervaluation compared to peers justify an upgrade to a "Buy" rating. Fortive's solid balance sheet, aggressive share repurchase policy, and stable cash flow position it well for superior medium-term returns. Read the full article on Seeking AlphaSeeking Alpha • Sep 22
Fortive: A Softer Performance Triggers A Separation
Summary Fortive is a solid conglomerate operating in three segments, focusing on intelligent operating solutions, precision technologies and healthcare solutions. After a softer performance of the precision technologies business this year, the company has announced plans to separate the business. The company trades at reasonable valuations and leverage, with a potential for higher valuation post-separation, expected to complete by Q4 2025. I recommend initiating positions in the $70s or high $60s, as the business separation may drive significant shareholder value. Read the full article on Seeking Alpha매출 및 비용 세부 내역
매출 및 비용 세부 내역
Fortive가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 03 Apr 26 | 4,235 | 557 | 1,670 | 262 |
| 31 Dec 25 | 4,159 | 533 | 1,661 | 259 |
| 26 Sep 25 | 6,260 | 885 | 2,185 | 421 |
| 27 Jun 25 | 6,237 | 879 | 2,165 | 421 |
| 28 Mar 25 | 3,550 | 388 | 1,498 | 211 |
| 31 Dec 24 | 4,081 | 483 | 1,651 | 251 |
| 27 Sep 24 | 4,592 | 555 | 1,774 | 285 |
| 28 Jun 24 | 5,083 | 661 | 1,870 | 322 |
| 29 Mar 24 | 6,129 | 900 | 2,119 | 402 |
| 31 Dec 23 | 3,914 | 408 | 1,667 | 237 |
| 29 Sep 23 | 6,012 | 828 | 2,025 | 400 |
| 30 Jun 23 | 5,973 | 800 | 2,012 | 403 |
| 31 Mar 23 | 5,910 | 764 | 1,983 | 403 |
| 31 Dec 22 | 5,826 | 755 | 1,956 | 402 |
| 30 Sep 22 | 5,671 | 696 | 1,943 | 393 |
| 01 Jul 22 | 5,516 | 659 | 1,907 | 380 |
| 01 Apr 22 | 5,372 | 650 | 1,878 | 368 |
| 31 Dec 21 | 5,255 | 580 | 1,842 | 355 |
| 01 Oct 21 | 5,205 | 1,646 | 1,747 | 345 |
| 02 Jul 21 | 5,064 | 1,562 | 1,727 | 337 |
| 02 Apr 21 | 4,786 | 1,440 | 1,700 | 326 |
| 31 Dec 20 | 4,634 | 1,383 | 1,732 | 321 |
| 25 Sep 20 | 2,556 | -147 | 1,246 | 212 |
| 26 Jun 20 | 3,256 | -26 | 1,377 | 252 |
| 27 Mar 20 | 4,079 | 90 | 1,486 | 292 |
| 31 Dec 19 | 4,564 | 199 | 1,582 | 320 |
| 27 Sep 19 | 7,075 | 718 | 2,058 | 454 |
| 28 Jun 19 | 6,816 | 724 | 1,932 | 439 |
| 29 Mar 19 | 6,553 | 816 | 1,800 | 423 |
| 31 Dec 18 | 3,800 | 455 | 1,221 | 278 |
| 28 Sep 18 | 5,602 | 837 | 1,522 | 378 |
| 29 Jun 18 | 5,686 | 909 | 1,463 | 376 |
| 30 Mar 18 | 5,713 | 899 | 1,415 | 373 |
| 31 Dec 17 | 5,756 | 884 | 1,378 | 369 |
| 29 Sep 17 | 6,476 | 932 | 1,438 | 397 |
| 30 Jun 17 | 6,359 | 891 | 1,409 | 390 |
| 31 Mar 17 | 6,285 | 890 | 1,402 | 387 |
| 31 Dec 16 | 5,378 | 740 | 1,264 | 351 |
| 30 Sep 16 | 6,173 | 884 | 1,352 | 377 |
| 01 Jul 16 | 6,130 | 854 | 1,347 | 377 |
| 01 Apr 16 | 6,140 | 842 | 1,331 | 376 |
| 31 Dec 15 | 6,179 | 864 | 1,334 | 378 |
| 02 Oct 15 | 6,290 | 857 | 1,392 | 384 |
양질의 수익: FTV는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: FTV의 현재 순 이익률 (13.1%)은 지난해 (11.3%)보다 높습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: FTV의 수익은 지난 5년 동안 연평균 16.8% 감소했습니다.
성장 가속화: 지난 1년간 FTV 의 수익 증가율(32.5%)은 연간 평균(-16.8%)을 초과합니다.
수익 대 산업: FTV의 지난 1년 수익 증가율(32.5%)은 Machinery 업계의 2.4%를 상회했습니다.
자기자본이익률
높은 ROE: FTV의 자본 수익률(9.1%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/06/09 13:59 |
| 종가 | 2026/06/09 00:00 |
| 수익 | 2026/04/03 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Fortive Corporation는 29명의 분석가가 다루고 있습니다. 이 중 15명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| John Eade | Argus Research Company |
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |